SCHEMBL3925828

SCHEMBL3925828

CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C#N.CN(C)c1ccc(C(=O)Cc2ccccc2Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.48
RAB9A P51151 6/20 0.48
SMN1; SMN2 Q16637 4/20 0.48
ALDH1A1 P00352 4/20 0.48
NPSR1 Q6W5P4 2/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
GLA P06280 1/20 0.48
CHEK1 O14757 3/20 0.43
EGFR P00533 3/20 0.43
KDR P35968 3/20 0.43
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.37
LMNA P02545 2/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
SIRT1 Q96EB6 1/20 0.37
DRD4 P21917 1/20 0.36
P2RY12 Q9H244 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304085 0.79 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL2303072 0.71 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL29256169 0.68 NPC1 (0.56) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL3086925 0.65 KDM4E (0.50) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL14019455 0.65 NPC1 (0.77) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL21313794 0.65 NPSR1 (0.58) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL11765664 0.64 NPC1 (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL17973839 0.63 NPC1 (0.70) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL17973838 0.63 NPC1 (0.70) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1
SCHEMBL9511161 0.63 ALDH1A1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP claimed
US-9889180-B2 Method of treating cancer AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-13 US claimed
US-20150258175-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-09-17 US claimed
EP-2908843-B1 TREATING CANCER AGENCY SCIENCE TECH & RES (SG) 2019-09-04 EP disclosed
US-9889180-B2 Method of treating cancer AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-13 US disclosed
US-20150258175-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-09-17 US disclosed
WO-2014077784-A1 METHOD OF TREATING CANCER AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-05-22 WO disclosed
WO-2009006577-A2 COMPOSITIONS AND METHODS FOR INHIBITING EZH2 THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2009-01-08 WO disclosed